J Korean Ophthalmol Soc.  2002 Mar;43(3):464-470.

Acrysof(R) and Polymethylmethacrylate Intraocular Lens Implantation in Diabetic Patients

Affiliations
  • 1Department of Ophthalmology, Chonnam University Medical School & Hospital Kwangju, Korea. kjyang@chonnam.ac.kr

Abstract


OBJECTIVE
To determine the efficacy of Acrysof(R) intraocular lens (IOL) compared to PMMA IOL about visual acuity & postoperative complications (eg. posterior capsular opacification) in diabetic patients.
PATIENTS AND METHODS
We retrospectively reviewed the medical records of 18 patients (21 eyes) which underwent cataract extraction with Acrysof (R) IOL implantation and 58 patients (65 eyes) with PMMA (polymethylmethacrylate) IOL implantation from January 1996 to December 1999 at Chonnam National University Hospital.
RESULTS
Postoperative best corrected visual acuity of above or equal to 0.5 was seem in 66.7% in acrysof (R) group, and in 73.9% in PMMA group at 6 months follow-up. Postoperative posterior capsular opacification was 33.3% and 49.2% respectively, and there was statistically significant difference in both group(p=0.021).
CONCLUSIONS
Acrysof(R) intraocular lens can be used safely and reduce the rate of posterior capsular opacification in diabetic patients, which can make the positive effect on the treatment of the diabetic retinopathy after cataract surgery.

Keyword

Acrysof; Cataract; Diabetes mellites; PMMA; Posterior capsular opacification

MeSH Terms

Cataract
Cataract Extraction
Diabetic Retinopathy
Follow-Up Studies
Humans
Jeollanam-do
Lens Implantation, Intraocular*
Lenses, Intraocular*
Medical Records
Polymethyl Methacrylate*
Postoperative Complications
Retrospective Studies
Visual Acuity
Polymethyl Methacrylate
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr